Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Occult primary malignancies.

A C Yeomans1, J B Washington

  • 1Division of Medicine, University of Texas M.D. Anderson Cancer Center, Houston.

Oncology Nursing Forum
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behavioral and social factors that predict participation in the Breast Cancer Prevention Trial.

Annals of the New York Academy of Sciences·1995
Same author

Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1993
Same author

Assessment and management of gouty arthritis.

The Nurse practitioner·1991
Same author

Assessment and management of hypothyroidism.

The Nurse practitioner·1990
Same author

Myelodysplastic syndromes.

Seminars in oncology nursing·1990
Same author

Hereditary cancer syndromes: implications for practice.

Dimensions in oncology nursing : journal of the Division of Nursing·1990

Occult primary malignancies (OPMs) present a poor prognosis, with survival typically two to four months. In over half of cases, the primary tumor remains unidentified despite extensive diagnostics, necessitating palliative care.

Area of Science:

  • Oncology
  • Cancer Research

Background:

  • Occult primary malignancies (OPMs) are a significant clinical challenge, ranking as the eighth most common cancer in the United States.
  • These cancers often present with a poor prognosis, characterized by a short survival period of two to four months post-diagnosis.

Purpose of the Study:

  • To review the diagnostic challenges and therapeutic implications of occult primary malignancies.
  • To highlight the nursing role in managing patients with OPMs.

Main Methods:

  • Review of existing literature and clinical data on occult primary malignancies.
  • Analysis of diagnostic workup effectiveness and autopsy findings.

Main Results:

  • In more than 50% of patients, the primary tumor remains undiscovered even after thorough investigation, including autopsy.

Related Experiment Videos

  • The majority of OPMs are diagnosed at a metastatic stage, limiting treatment options to palliative care.

    • Conclusions:

    • Occult primary malignancies are associated with aggressive disease and limited treatment efficacy.
    • Effective nursing care, focusing on symptom management, psychological support, and patient education, is crucial for improving the quality of life for patients with OPMs.